Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of MAP0004 in Adult Migraineurs clinical trial (NCT00623636). Contact the study team or your healthcare provider for specific answers.

Question 2

How will I know if I am receiving MAP0004 or the placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of MAP0004 in Adult Migraineurs clinical trial (NCT00623636). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of MAP0004 in Adult Migraineurs clinical trial (NCT00623636). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of MAP0004 in Adult Migraineurs clinical trial (NCT00623636). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience a severe migraine during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of MAP0004 in Adult Migraineurs clinical trial (NCT00623636). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase 3 Study of MAP0004 in Adult Migraineurs clinical trial (NCT00623636). Contact the study team or your healthcare provider for specific answers.

What this study is about